Literature DB >> 23598963

A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis.

Teresa M Neuhann1, Veit Mansmann, Sabine Merkelbach-Bruse, Barbara Klink, Achim Hellinger, Heinz-Gert Höffkes, Eva Wardelmann, Hans-Ulrich Schildhaus, Sigrid Tinschert.   

Abstract

Familial gastrointestinal stromal tumor (GIST) syndrome is a rare autosomal dominant genetic disorder. We report on a kindred in which 3 family members carry a germline mutation (c.1727T>C, p.L576P) in exon 11 of the KIT gene. This mutation was not reported so far in familial GISTs. Apart from multiple GISTs in 2 of the mutation carriers, all of them had multiple hyperpigmented skin macules and a history of achalasia-like stenosis of the esophagus in early childhood. In the index patient >100 tumors and a diffuse Cajal cell hyperplasia of the small bowel occurred. Sequencing of DNA extracted from tumor tissue of one of his GISTs revealed the KIT mutation in exon 11 (c.1727T>C). By array comparative genomic hybridization whole chromosomal gains 3, 5, 7, 9, 12, 15, and 18 were detected. In addition, we could identify a gain on chromosome 4, spanning the KIT gene. Together with the family described here, 24 unrelated cases with proven germline mutations in KIT have been reported. In these families the diagnosis was established from the age of 30 years onwards. Because in 1 patient reported here the GIST was a coincidental finding at the age of 15 years, the tumors might occur at a very young age and remain unnoticed until they-either due to increasing size, ulceration, or malignant progression-become symptomatic. Therefore, we propose to start screening patients with known KIT mutations from a younger age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598963     DOI: 10.1097/PAS.0b013e31827bc071

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Authors:  James D Murphy; Grace L Ma; Joel M Baumgartner; Lisa Madlensky; Adam M Burgoyne; Chih-Min Tang; Maria Elena Martinez; Jason K Sicklick
Journal:  Cancer       Date:  2015-04-30       Impact factor: 6.860

2.  Characterization of various types of mast cells derived from model mice of familial gastrointestinal stromal tumors with KIT-Asp818Tyr mutation.

Authors:  Noriko Kajimoto; Norihiro Nakai; Mizuka Ohkouchi; Yuka Hashikura; Ning-Ning Liu-Kimura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).

Authors:  Rita Vale Rodrigues; Filipa Santos; João Pereira da Silva; Inês Francisco; Isabel Claro; Cristina Albuquerque; Maria Manuel Lemos; Manuel Limbert; António Dias Pereira
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

4.  Surgical Management of Adolescents and Young Adults With Gastrointestinal Stromal Tumors: A US Population-Based Analysis.

Authors:  Katherine E Fero; Taylor M Coe; Paul T Fanta; Chih-Min Tang; James D Murphy; Jason K Sicklick
Journal:  JAMA Surg       Date:  2017-05-01       Impact factor: 14.766

Review 5.  Syndromic gastrointestinal stromal tumors.

Authors:  Riccardo Ricci
Journal:  Hered Cancer Clin Pract       Date:  2016-07-19       Impact factor: 2.857

Review 6.  Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis.

Authors:  Hengning Ke; Julhash U Kazi; Hui Zhao; Jianmin Sun
Journal:  Cell Biosci       Date:  2016-10-18       Impact factor: 7.133

7.  Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumors.

Authors:  Feiyang Liu; Fengming Zou; Cheng Chen; Kailin Yu; Xiaochuan Liu; Shuang Qi; Jiaxin Wu; Chen Hu; Zhenquan Hu; Juan Liu; Xuesong Liu; Li Wang; Juan Ge; Wenchao Wang; Tao Ren; Mingfeng Bai; Yujiao Cai; Xudong Xiao; Feng Qian; Jun Tang; Qingsong Liu; Jing Liu
Journal:  Ther Adv Med Oncol       Date:  2019-05-17       Impact factor: 8.168

8.  Multiple gastrointestinal stromal tumors: analysis of clinicopathologic characteristics and prognosis of 20 patients.

Authors:  Kai Li; Weh Tjhoi; Chunhui Shou; Weili Yang; Qing Zhang; Xiaosun Liu; Jiren Yu
Journal:  Cancer Manag Res       Date:  2019-07-25       Impact factor: 3.989

Review 9.  The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.

Authors:  Francisco Tustumi; Jorge Henrique Bento de Sousa; Nicolas Medeiros Dornelas; Guilherme Maganha Rosa; Milton Steinman; Edno Tales Bianchi
Journal:  Med Sci (Basel)       Date:  2021-05-21

10.  Cellular and molecular mechanism study of declined intestinal transit function in the cholesterol gallstone formation process of the guinea pig.

Authors:  Ying Fan; Shuodong Wu; Zhenhua Yin; Bei-Bei Fu
Journal:  Exp Ther Med       Date:  2014-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.